285 related articles for article (PubMed ID: 27130930)
1. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women.
Mirabello L; Yeager M; Cullen M; Boland JF; Chen Z; Wentzensen N; Zhang X; Yu K; Yang Q; Mitchell J; Roberson D; Bass S; Xiao Y; Burdett L; Raine-Bennett T; Lorey T; Castle PE; Burk RD; Schiffman M
J Natl Cancer Inst; 2016 Sep; 108(9):. PubMed ID: 27130930
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.
Clifford GM; Tenet V; Georges D; Alemany L; Pavón MA; Chen Z; Yeager M; Cullen M; Boland JF; Bass S; Steinberg M; Raine-Bennett T; Lorey T; Wentzensen N; Walker J; Zuna R; Schiffman M; Mirabello L
Papillomavirus Res; 2019 Jun; 7():67-74. PubMed ID: 30738204
[TBL] [Abstract][Full Text] [Related]
4. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix.
Quint KD; de Koning MN; van Doorn LJ; Quint WG; Pirog EC
Gynecol Oncol; 2010 May; 117(2):297-301. PubMed ID: 20207397
[TBL] [Abstract][Full Text] [Related]
5. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
Befano B; Wentzensen N; Lorey T; Poitras N; Cheung LC; Schiffman M; Clarke MA; Cohen C; Kinney W; Locke A; Castle PE
Gynecol Oncol; 2024 May; 184():89-95. PubMed ID: 38301311
[TBL] [Abstract][Full Text] [Related]
6. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
7. Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.
Alfaro A; Juárez-Torres E; Medina-Martínez I; Mateos-Guerrero N; Bautista-Huerta M; Román-Bassaure E; Villegas-Sepúlveda N; Berumen J
PLoS One; 2016; 11(12):e0169315. PubMed ID: 28036379
[TBL] [Abstract][Full Text] [Related]
8. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008-2015.
Cleveland AA; Gargano JW; Park IU; Griffin MR; Niccolai LM; Powell M; Bennett NM; Saadeh K; Pemmaraju M; Higgins K; Ehlers S; Scahill M; Johnson Jones ML; Querec T; Markowitz LE; Unger ER;
Int J Cancer; 2020 Feb; 146(3):810-818. PubMed ID: 30980692
[TBL] [Abstract][Full Text] [Related]
9. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
[TBL] [Abstract][Full Text] [Related]
11. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Castle PE; Solomon D; Schiffman M; Wheeler CM
J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
[TBL] [Abstract][Full Text] [Related]
13. Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women.
Liu Y; Pan Y; Gao W; Ke Y; Lu Z
Sci Rep; 2017 Mar; 7(1):263. PubMed ID: 28325903
[TBL] [Abstract][Full Text] [Related]
14. Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions.
Hirose Y; Onuki M; Tenjimbayashi Y; Yamaguchi-Naka M; Mori S; Tasaka N; Satoh T; Morisada T; Iwata T; Kiyono T; Mimura T; Sekizawa A; Matsumoto K; Kukimoto I
Viruses; 2019 Apr; 11(4):. PubMed ID: 30995759
[TBL] [Abstract][Full Text] [Related]
15. The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.
Lou H; Boland JF; Torres-Gonzalez E; Albanez A; Zhou W; Steinberg MK; Diaw L; Mitchell J; Roberson D; Cullen M; Garland L; Bass S; Burk RD; Yeager M; Wentzensen N; Schiffman M; Freites EA; Gharzouzi E; Mirabello L; Dean M
Cancer Res; 2020 Sep; 80(18):3803-3809. PubMed ID: 32631904
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
[TBL] [Abstract][Full Text] [Related]
17. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.
Mirabello L; Sun C; Ghosh A; Rodriguez AC; Schiffman M; Wentzensen N; Hildesheim A; Herrero R; Wacholder S; Lorincz A; Burk RD
J Natl Cancer Inst; 2012 Apr; 104(7):556-65. PubMed ID: 22448030
[TBL] [Abstract][Full Text] [Related]
18. Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014.
McClung NM; Gargano JW; Bennett NM; Niccolai LM; Abdullah N; Griffin MR; Park IU; Cleveland AA; Querec TD; Unger ER; Markowitz LE;
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):602-609. PubMed ID: 30792242
[TBL] [Abstract][Full Text] [Related]
19. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
20. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
